Long-term use of metformin and the molecular subtype in invasive breast carcinoma patients – a retrospective study of clinical and tumor characteristics

BACKGROUND: Metformin may exhibit inhibitory effects on cancer cells by inhibiting mTOR signaling pathway. The aim of our retrospective study was to examine if patients with breast carcinoma (BC) and diabetes mellitus (DM) receiving metformin have a lower stage of carcinoma in comparison to patients...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Besic, Nikola, Satej, Nika, Ratosa, Ivica, Horvat, Andreja Gojkovic, Marinko, Tanja, Gazic, Barbara, Petric, Rok
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2014
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4005811/
https://ncbi.nlm.nih.gov/pubmed/24774412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-298
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia